• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用血清素能迷幻剂的动机:一项系统综述。

Motives for the use of serotonergic psychedelics: A systematic review.

作者信息

Basedow Lukas A, Kuitunen-Paul Sören

机构信息

MIND Foundation, Berlin, Germany.

Department of Clinical Psychology and Psychotherapy, Technische Universität Chemnitz, Chemnitz, Germany.

出版信息

Drug Alcohol Rev. 2022 Sep;41(6):1391-1403. doi: 10.1111/dar.13480. Epub 2022 Jun 6.

DOI:10.1111/dar.13480
PMID:35668698
Abstract

ISSUES

Serotonergic psychedelics (SP) are psychoactive substances that produce unique sets of subjective effects, such as hallucinatory experiences. This systematic review is the first to summarise which motives for SP use have been assessed in medical, psychological, sociological and ethnological research across different types of SPs and across cultural backgrounds. Findings on use motives can be especially important in the context of harm reduction.

APPROACH

We searched academic databases (Medline, Web of Science and Embase) and included publications if they were peer-reviewed and written in English, German, Spanish or Dutch. We analysed which type of motives were reported, comparing motives from quantitative and qualitative reports, and investigating associations between motives and year of publication, specific SPs and specific participant populations.

KEY FINDINGS

Our search in November 2020 resulted in 30,257 unique articles of which 37 were included in the analysis. Across all studies, the most common motive for SP use was the desire to expand awareness (78% of included studies), followed by coping (67%) and enhancement (57%) motives. There were no statistically significant associations between reported motive and type of report (quantitative vs. qualitative), year of publication (range: 1967-2020), type of SP and participant population.

IMPLICATIONS

If SP-related harms are to be reduced, harm-reduction services could focus on providing non-pharmacological ways of fulfilling an expansion motive. Additionally, future studies should aim to assess specific motives for specific SPs.

CONCLUSIONS

SPs are most commonly used to expand (self-)knowledge, promote spiritual development or for curiosity, notably across different SP user populations including patients.

摘要

问题

血清素能致幻剂(SP)是一类精神活性物质,会产生独特的主观效应,如幻觉体验。本系统综述首次总结了在医学、心理学、社会学和民族学研究中,针对不同类型的血清素能致幻剂以及不同文化背景下,使用血清素能致幻剂的动机有哪些已得到评估。在减少伤害的背景下,关于使用动机的研究结果可能尤为重要。

方法

我们检索了学术数据库(Medline、科学网和Embase),纳入经过同行评审且以英语、德语、西班牙语或荷兰语撰写的出版物。我们分析了所报告的动机类型,比较了定量和定性报告中的动机,并研究了动机与出版年份、特定血清素能致幻剂以及特定参与者群体之间的关联。

主要发现

我们在2020年11月进行的检索共得到30257篇独特文章,其中37篇被纳入分析。在所有研究中,使用血清素能致幻剂最常见的动机是渴望拓展意识(78%的纳入研究),其次是应对(67%)和增强(57%)动机。所报告的动机与报告类型(定量与定性)、出版年份(范围:1967 - 2020年)、血清素能致幻剂类型以及参与者群体之间均无统计学上的显著关联。

启示

若要减少与血清素能致幻剂相关的危害,减少伤害服务可侧重于提供非药物方式来满足拓展动机。此外,未来研究应旨在评估特定血清素能致幻剂的特定动机。

结论

血清素能致幻剂最常用于拓展(自我)认知、促进精神发展或出于好奇心,尤其是在包括患者在内的不同血清素能致幻剂使用者群体中。

相似文献

1
Motives for the use of serotonergic psychedelics: A systematic review.使用血清素能迷幻剂的动机:一项系统综述。
Drug Alcohol Rev. 2022 Sep;41(6):1391-1403. doi: 10.1111/dar.13480. Epub 2022 Jun 6.
2
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
3
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
6
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
7
Interventions for infantile haemangiomas of the skin.皮肤婴儿血管瘤的干预措施。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD006545. doi: 10.1002/14651858.CD006545.pub3.
8
Electronic cigarettes for smoking cessation.用于戒烟的电子烟。
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub9.
9
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2024 Jan 8;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub8.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

引用本文的文献

1
Population-based estimates of different dosage types of psychedelic use across socio-demographic groups in Germany.基于德国不同社会人口群体的迷幻剂使用不同剂量类型的人群估计。
Sci Rep. 2025 May 29;15(1):18952. doi: 10.1038/s41598-025-03873-0.
2
A landscape analysis of psychedelic retreat organizations advertising online.对在线宣传的迷幻静修组织的景观分析。
PLoS One. 2025 May 2;20(5):e0321648. doi: 10.1371/journal.pone.0321648. eCollection 2025.
3
Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.
迷幻剂研究参与的动机与回顾性评价:一项针对健康志愿者的定性研究
Psychopharmacology (Berl). 2025 Mar 26. doi: 10.1007/s00213-025-06772-4.
4
Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors.使用迷幻剂对冥想练习有益吗?审视个体、迷幻剂及与冥想相关的因素。
PLoS One. 2025 Feb 12;20(2):e0310160. doi: 10.1371/journal.pone.0310160. eCollection 2025.
5
Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors.使用迷幻药能否有益于冥想练习?探究个体、迷幻药及与冥想相关的因素。
medRxiv. 2024 Aug 28:2024.08.27.24312677. doi: 10.1101/2024.08.27.24312677.
6
From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions.从混沌到万花筒:探索迷幻自我治疗心理健康状况的因素。
J Psychopharmacol. 2024 Aug;38(8):749-760. doi: 10.1177/02698811241265762. Epub 2024 Jul 29.
7
Psychotomimetic compensation versus sensitization.精神拟态补偿与敏化。
Pharmacol Res Perspect. 2024 Aug;12(4):e1217. doi: 10.1002/prp2.1217.
8
Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder.解锁裸盖菇素的治疗潜力:裸盖菇素疗法在重度抑郁症、强迫症和物质使用障碍中的作用概述
Front Psychiatry. 2024 Jun 11;15:1406888. doi: 10.3389/fpsyt.2024.1406888. eCollection 2024.
9
Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ).测量迷幻体验背景下的心理治疗过程:通用变化机制问卷(GCMQ)的验证。
J Psychopharmacol. 2024 May;38(5):432-457. doi: 10.1177/02698811241249698. Epub 2024 May 14.